OBJECTIVE: The objective was to compare the efficacy of motivational enhancement therapy coupled with cognitive behavioral therapy (MET-CBT) to brief advice for treatment of substance use in pregnancy. METHOD: This was a randomized, parallel, controlled trial that was yoked to prenatal care and delivered at hospital outpatient clinics. We enrolled 168 substance-using women who had not yet completed an estimated 28 weeks of pregnancy. Obstetrical clinicians provided brief advice, and study nurses administered manualized MET-CBT. The primary outcome was percentage of days in the prior 28 days in whichalcohol and/or drugs were used immediately before and 3 months postdelivery. RESULTS: There were no significant differences across groups in terms of self-reported percentage of days in which drugs or alcohol were used prior to and 3 months postdelivery. Biological measures showed similar results. There was a trend (P=.08) for lower risk of preterm birth among those who received MET-CBT. CONCLUSIONS: The tested interventions had similar therapeutic effects. Hence, both treatments may be suitable for pregnant substance users, depending on the population, setting and provider availability. Interventions that are intensified after delivery may decrease postpartum "rebound" effects in substance misuse.
RCT Entities:
OBJECTIVE: The objective was to compare the efficacy of motivational enhancement therapy coupled with cognitive behavioral therapy (MET-CBT) to brief advice for treatment of substance use in pregnancy. METHOD: This was a randomized, parallel, controlled trial that was yoked to prenatal care and delivered at hospital outpatient clinics. We enrolled 168 substance-using women who had not yet completed an estimated 28 weeks of pregnancy. Obstetrical clinicians provided brief advice, and study nurses administered manualized MET-CBT. The primary outcome was percentage of days in the prior 28 days in which alcohol and/or drugs were used immediately before and 3 months postdelivery. RESULTS: There were no significant differences across groups in terms of self-reported percentage of days in which drugs or alcohol were used prior to and 3 months postdelivery. Biological measures showed similar results. There was a trend (P=.08) for lower risk of preterm birth among those who received MET-CBT. CONCLUSIONS: The tested interventions had similar therapeutic effects. Hence, both treatments may be suitable for pregnant substance users, depending on the population, setting and provider availability. Interventions that are intensified after delivery may decrease postpartum "rebound" effects in substance misuse.
Authors: Grace Chang; Tay K McNamara; E John Orav; Danielle Koby; Alyson Lavigne; Barbara Ludman; Nori Ann Vincitorio; Louise Wilkins-Haug Journal: Obstet Gynecol Date: 2005-05 Impact factor: 7.661
Authors: M A Armstrong; L Lieberman; D M Carpenter; V M Gonzales; M S Usatin; L Newman; G J Escobar Journal: Qual Manag Health Care Date: 2001 Impact factor: 0.926
Authors: Derek G Moore; John D Turner; Andrew C Parrott; Julia E Goodwin; Sarah E Fulton; Meeyoung O Min; Helen C Fox; Fleur M B Braddick; Emma L Axelsson; Stephanie Lynch; Helena Ribeiro; Caroline J Frostick; Lynn T Singer Journal: J Psychopharmacol Date: 2009-11-25 Impact factor: 4.153
Authors: Kimberly Ann Yonkers; Heather B Howell; Amy E Allen; Samuel A Ball; Michael V Pantalon; Bruce J Rounsaville Journal: Arch Womens Ment Health Date: 2009-04-07 Impact factor: 3.633
Authors: Sarah H Heil; Stephen T Higgins; Ira M Bernstein; Laura J Solomon; Randall E Rogers; Colleen S Thomas; Gary J Badger; Mary Ellen Lynch Journal: Addiction Date: 2008-06 Impact factor: 6.526
Authors: Wenhao Dai; Ryan Palmer; Aashna Sunderrajan; Marta Durantini; Flor Sánchez; Laura R Glasman; Fan Xuan Chen; Dolores Albarracín Journal: Psychol Addict Behav Date: 2020-04-20